Scientific Program

Session 1: OPENING  

Chair: Prof. Gilbert Donders (BE) ISIDOG President

Welcome Introduction
Gilbert Donders (BE) & Istvan Sziller (HU) 
Laudatio - Bill Ledger 
Steven Witkin (US) 
Keynote Lecture: How COVID affects Gynecology & Medicine
Marleen Temmerman (Kenya)

Session 2:  Free Oral Communications #1 (Pregnancy) 

Chair: Prof. Ljubomir Petricevic (AT)

F.1 Mixed vaginitis in 3rd trimester of pregnancy is associated with adverse pregnancy outcomes: A cross-sectional study.   
Li Huanrong,  Xue Fengxia (Tianjin, PRC)  
F.2 Do pregnant women with obstetric medical history have a vaginal microbiome associated with higher recurrence risk of preterm birth?  
Sanne Laurijssen, Gilbert Donders, Yves Jacquemyn, Sarah Lebeer (Antwerp, BE) 
F.3 In-vitro study of polybacterial infection of chorioamniotic membranes: modulation of immune response at maternal-fetal interface.
Giovana Bento
, Mariana de Castro Silva, Geovanna Cristofani Cursino, Carolina Santimaria Rampazzo, Guiherme Nastaro, Jossimara Polettini, Marcia Guimarães da Silva (São Paolo, BR) 

Session 3: Obstetric & Neonatal Microbiology 

Chairs: Prof. Dace Rezeberga (LV) , Prof. Daniel Surbek (CH) 

Marian Kacerovsky (CZ)
Vaginitis/Vaginosis in pregnancy in East Congo 
Lisa Himschoot (BE)
Vaginal viruses in pregnancy 
Steven Witkin (US) 
Caesarean section, microbiome & childhood development 
Daniel Surbek (CH)  

Session 4: Prevention of Materno-Fetal Infection

Chair: Prof. Istvan Sziller (HU)

Mycoplasma genitalium in women in Germany 
Anja Potthoff (DE)
Maternal immunization  
Kirsten Maertens (BE) 
SARS-CoV-2 vaccination 
Svitrigaile Grinceviene (LT) 
Clinical conundrum: Two maternal sepsis deaths 
Peter Greenhouse (GB) 

Session 5: Lunch Symposium sponsored by Medinova 

Update on “ProPreB” trial 
Prof. Gilbert Donders (BE) 
Management of abnormal flora in pregnancy  
Prof. Daniel Surbek (CH) 

Session 6: Free Oral Communications #2 (Bacterial Vaginitis) 

Chair: Dr. Peter Greenhouse (GB) 

F.4 Aerobic Vaginitis diagnosis criteria combining Gram stain with clinical features: An establishment and prospective validation study      
Dong Mengting (Tianjing, PRC) 
F.5 Vaginal microbial profiles of Aerobic Vaginitis: A case-control study      
Wang Chen (Tianjing, PRC) 
F.6 Characteristics & diagnostic ability of vaginal microflora in patients with Aerobic Vaginitis: A comparative study with 16S-RNA sequencing   
Zeng Zhen, Zhang Qiongqiong, Zhang Lei (Beijing, PRC) 
F.7 Cervicovaginal load of Gardnerella spp. is increased in immunocompetent women with persistent high-risk HPV Infection
Rafael Belleti, Larissa Doddi Marcolino, Juliano Novak, Carolina Sanitá Tafner Ferreira, Aline do Nascimento Bolpetti, Gabriel da Silva Pinto, Gabriel Vitor, Ana Cristina Palmeira de Oliveira, Marcia Guimarães da Silva, Camila Marconi (São Paolo, BR) 
F.8 Association of vaginal microecology and Cervical Intraepithelial Neoplasia among reproductive women with high-risk HPV Infection.      
Li Huiyang, Xie Wenjuan, Dong Mengting (Tianjing, PRC) 
F.9 The use of menstrual cups is associated with the maintenance of healthy vaginal microbiota.      
Bruna Ribeiro de Andrade Ramos, Júlia Abbade Tronco, Jeniffer Sena Baptista Ferreira, Mariana de Castro Silva, Mariana Alice de Oliveira Ignácio, Beatriz Cassolatti Graciolli, Marli Terezinha Cassamassimo Duarte, Márcia Guimarães Da Silva (São Paolo, BR) 

Session 7: Vulvo-Vaginal Infections #1 

Chair: Prof. Gilbert Donders (BE)  

Clinical recommendations on mixed vaginitis 
Qi Wenhui (PRC) 
Lichen sclerosus and vulvodynia
Werner Mendling (DE) 
Treatment options for bacterial vaginosis 
Jack Sobel (US) 

Session 8: Vulvo-Vaginal Infections #2 

Chair: Prof. Werner Mendling (DE)  

What can we learn from vaginal microbiome analysis? 
Sarah Lebeer (BE) 
Isala project: citizen-science mapping of the vaginal microbiome structure and determinants
Sarah Ahannah (BE)  
Aerobic Vaginitis as an immune disorder 
Werner Mendling (DE) 

Session 9: Free Oral Communications #3 (Candida & Other) 

Chair: Prof. Gilbert Donders (BE) 

F.10 Advances in vaginal microecology theory in the application of vulvovaginal candidiasis.   
Ma Xiaotong (Tianjing, PRC) 
F.11 Candida biofilms in vulvovaginal candidiasis.  
Carmen Rodriguez-Cerdeira, Roberto Arenas (Vigo, ES) 
F.12 Three phase 3, randomized, double-blind, placebo-controlled studies to evaluate the efficacy and safety of Oteseconazole (Vt-1161) oral capsules in subjects with recurrent vulvovaginal candidiasis. 
Gilbert Donders, Jack Sobel, Mark Martens, Bassem Maximos, Mahmoud Ghannoum, Amy Flynt, Thorsten Degenhardt, Karen Person, Stacey Curelop, Stephen Brand (Antwerp, BE) 
F.13 Efficacy and safety of oral Ibrexafungerp in subjects with vulvovaginal candidiasis: Pooled data analysis from two phase 3, randomized, blinded, studies vs. placebo (VANISH-303 and VANISH-306).
Nkechi Azie, David Angulo (US) 
F.14 Dyspareunia in women: is it always vulvodynia?  
Jente Reumers, Gilbert Donders, Francesca Donders (Tienen, BE) 

Session 10: Sexually Transmitted Infections  

Chairs: Dr. Peter Greenhouse (GB), Dr. Tatiana Ivanova-Rumantseva (RF) 

Access to STI & HIV testing during the COVID-19 restrictions 
Dace Rezeberga (LV) 
HPV and fertility 
Christophe Depuydt (BE) 
Rectal & extra-genital chlamydial infection - “FemCure” Study            
Nicole Dukers-Muijrers (NL) 
HPV and genital cancer in LBGTQIA+ populations 
Mikael Skerlev (HR) 
Sex parties and STI prevalence 
Tatiana Ivanova-Rumantseva (RF) 

Session 11: Lunch Symposium sponsored by Bayer  

Vaginal and gut microbiome – a cross talk 
Prof. Werner Mendling (DE) 
Managing women with recurrent bacterial vaginosis: how does the VITA trial (lactic acid gel versus metronidazole) help inform practice
Prof. Jonathan Ross (GB) 

Session 12: Lunch Symposium sponsored by Gedeon Richter

RVVC: Towards an optimised diagnosis 
Prof. Istvan Sziller (HU)
RVVC: Towards an optimised therapeutic approach
Prof. Gilbert Donders (BE) 

Session 13: Pro- and Pre-Biotics 

Chairs: Prof. Ljubomir Petricevic (AT), Prof. Sarah Lebeer (BE) 

Antifungals versus probiotrics against candidal vaginitis?
Sarah Lebeer (BE) 
Do oral probiotics influence the vaginal microbiome? 
Ljubomir Petricevic (AT) 
Testing of pre- and pro-biotic treatments
Joana Rolo (PT)
Gardenella-specific endolysin treatment of metronidazole-resistant and clindamycin-tolerant bacterial vaginosis  
Lorenzo Corsini (IT) 

Session 14: COVID impact on Women’s Health 

Chairs: Prof. Gilbert Donders (BE), Prof. Istvan Sziller (HU) 

COVID and sperm 
Jente Reumers (BE) 
ISIDOG guidelines for COVID in pregnancy 
Francesca Donders (BE) 
COVID and the placenta 
Zsofia Zolnai (HU) 
Impact of social media & COVID on STI epidemiology 
Peter Greenhouse (GB) 

Conference Closing Ceremony and Awards ISIDOG Board